Nika Jutraž, Katja Perdan Pirkmajer, Bor Hrvatin Stančič
{"title":"Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review.","authors":"Nika Jutraž, Katja Perdan Pirkmajer, Bor Hrvatin Stančič","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Amyopathic dermatomyositis (AD) is an autoimmune connective tissue disease of uncertain etiology that comprises 20% to 30% of dermatomyositis patients. Multiple studies suggest an association between malignancies and AD; moreover, some also report fulminant lung disease in patients with AD. We present a 62-year-old female patient with severe clinical presentation of AD, characterized by diffuse severe alopecia and pronounced symmetrical livid edema of the upper and lower eyelid, and positive anti-melanoma differentiation-associated gene 5 (anti-MDA-5) antibodies, who was successfully treated with concurrent therapy with hydroxychloroquine, methylprednisolone, and methotrexate as well as topical corticosteroids. Underlying malignancies or lung disease were excluded. Furthermore, we recommend vigilance in the key differential diagnosis of cutaneous lupus erythematosus because they can both present with similar clinical and histopathological features. The remission correlated with the complete absence of anti-MDA-5 antibodies.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":" ","pages":"actaapa.2026.13"},"PeriodicalIF":1.0,"publicationDate":"2026-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147785147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maja Vilotijevic, Danijela Milcic, Branislav Lekic, Martina Bosic, Dusan Skiljevic, Mirjana Milinkovic Sreckovic
{"title":"A rare case of generalized bullous fixed drug eruption resembling toxic epidermal necrolysis.","authors":"Maja Vilotijevic, Danijela Milcic, Branislav Lekic, Martina Bosic, Dusan Skiljevic, Mirjana Milinkovic Sreckovic","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Generalized bullous fixed drug eruption (GBFDE) is a rare and severe adverse drug reaction characterized by widespread blisters and erosions involving at least 10% of the body surface. GBFDE can mimic Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), both clinically and histologically. We present the case of a 76-year-old woman with extensive painful blisters and erosions affecting approximately 70% of her skin, including the oral and genital mucosa, accompanied by an impaired general condition, strongly suggesting TEN. However, the absence of Nikolsky's sign, together with slate-gray hyperpigmentation, pointed toward GBFDE, later supported by histopathological analysis. Paracetamol was identified as the most likely causative agent. Following discontinuation of the culprit drug, the patient was treated with high-dose corticosteroids and antibiotics within a multidisciplinary care approach. After 3 weeks of hospitalization, the skin lesions healed with residual hyperpigmentation, and her condition stabilized. Our case highlights the challenge of differentiating between two uncommon severe disorders with overlapping clinical and histopathological features, including extensive epidermal necrosis and subepidermal blistering. Clinical and pathological correlation by experienced physicians is essential for distinguishing GBFDE from TEN because their management strategies differ, impacting both patient outcomes and healthcare costs.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":" ","pages":"actaapa.2026.12"},"PeriodicalIF":1.0,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147785059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Herpes zoster-like reaction triggered by the recombinant vaccine against herpes zoster (Shingrix).","authors":"Miloš D Pavlović, Violeta Hosta","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Zosteriform reactions triggered by the recombinant shingles vaccine (Shingrix) have been described in only two patients although many more cases that might be dermatomal seem to have been reported to regulatory agencies. It appears that these reactions may be caused by two different pathomechanisms: paradoxical reactivation of varicella zoster virus (VZV) or immune-mediated reactivity to already deposited virus or its antigens boosted by the vaccine. Our patient's cutaneous reaction favors the latter explanation because she developed quite a disseminated reaction that did not respond to oral valacyclovir. Apart from the interesting immunological underpinnings of the reactions, these reports suggest that physicians should test such lesions for the presence of VZV DNA to guide management. If viral DNA is absent and/or antivirals fail, a short-term course of oral corticosteroids should be considered.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":" ","pages":"actaapa.2026.11"},"PeriodicalIF":1.0,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147646978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of methotrexate and its influence on serum autoantibodies against BP180 in patients with bullous pemphigoid: a pilot study.","authors":"Riccardo Balestri, Giacomo Clarizio, Giulia Rech, Federica Filippi, Lidia Sacchelli, Camilla Loi, Federico Bardazzi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"35 1","pages":"61-62"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147595479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility.","authors":"Aleksandar Godic, Jaiden Townsend","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Intravenous administration of high-dose vitamins, minerals, amino acids, coenzyme Q10, α-lipoic acid, glutathione, and nicotinamide adenine dinucleotide has emerged as a popular longevity therapy, targeting key molecular processes, oxidative stress, mitochondrial decline, chronic inflammation, and genomic instability, which drive and accelerate aging. The rationale is that intravenous administration facilitates supraphysiological plasma concentrations, bypassing gastrointestinal absorption limitations to more effectively target these age-promoting mechanisms. Evidence from preclinical models and small clinical series reports transient reductions in oxidative biomarkers, modest improvements in fatigue syndromes, and anecdotal enhancements in skin elasticity. However, these findings are predominantly derived from disease-specific or aesthetic contexts rather than studies involving healthy aging populations. Crucially, few studies incorporate validated biomarkers of aging such as epigenetic age or telomere length, and placebo-controlled trials are scarce and underpowered or they yield conflicting results. Additional challenges include pharmacokinetic limitations, procedural risks, and substantial heterogeneity of infusion protocols, all of which hinder reliable interpretation. Until rigorously designed, adequately powered randomized controlled trials demonstrate reproducible long-term efficacy and safety, intravenous longevity therapy should be regarded as an experimental intervention rather than an evidence-based dermatological or anti-aging practice.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"35 1","pages":"39-43"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147594613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nikola Pantić, Jelena Pantović, Milica Kotur, Simona Petričević, Olga Radivojević, Katja Petrović, Nevena Vujošević, Lenka Grujičić, Isidora Grozdić Milojević, Dragana Šobić Šaranović, Vera Artiko, Strahinja Odalović
{"title":"Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience.","authors":"Nikola Pantić, Jelena Pantović, Milica Kotur, Simona Petričević, Olga Radivojević, Katja Petrović, Nevena Vujošević, Lenka Grujičić, Isidora Grozdić Milojević, Dragana Šobić Šaranović, Vera Artiko, Strahinja Odalović","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Cutaneous melanoma (CM) is the most aggressive cutaneous malignancy. The aim of the study was to determine the predictive value of primary tumor histopathologic features and laboratory findings used in routine CM follow-up for sentinel lymph node biopsy (SLNB) results and progression-free survival (PFS).</p><p><strong>Methods: </strong>This retrospective study included 157 patients. Planar images were acquired after an intradermal injection of 18 to 30 MBq of 99mTc-nanocolloid in 0.3 ml at two to eight sites 5 to 10 mm from the surgical scar. SLN excision was performed a day after lymphoscintigraphy.</p><p><strong>Results: </strong>In a logistic regression analysis, Breslow thickness, ulceration status, and mitotic rate showed possible predictive significance for SLNB results, with serum lactate dehydrogenase (LDH) being the only independent predictor (p = 0.042). The difference in survival distributions reached statistical significance for Breslow thickness, mitotic rate, and LDH (p < 0.05, Kaplan-Meier, log-rank test). In a Cox regression analysis, Breslow thickness was a possible predictor of PFS and mitotic rate was an independent predictor (p = 0.025).</p><p><strong>Conclusions: </strong>LDH is an independent predictor of SLN histopathology findings, and mitotic rate is an independent predictor of PFS.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":" ","pages":"13-20"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146229206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical features of 109 patients with primary cicatricial alopecia: a 15-year retrospective study.","authors":"Özge Zorlu, Hülya Albayrak, Sema Aytekin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Given the limited data on primary cicatricial alopecias (PCAs), which cause permanent hair loss, this study investigates the demographic and clinical characteristics, applied treatments, and disease course of PCA patients.</p><p><strong>Methods: </strong>Medical records of 109 PCA patients that attended an outpatient clinic between 2010 and 2025 were retrospectively reviewed. Demographic and clinical characteristics, and treatment approaches were retrieved from patient files.</p><p><strong>Results: </strong>Lymphocytic PCA (83.5%) was the most frequent type, followed by neutrophilic PCA (15.6%). Classic lichen planopilaris (LPP-C) was the leading lymphocytic subtype (39.4%), and folliculitis decalvans (12%) was the most common neutrophilic PCA. Lymphocytic PCAs showed female predominance, whereas male predominance was present in neutrophilic PCAs (p < 0.001). Disease onset occurred at an older age in lymphocytic PCAs compared to the neutrophilic group (42.0 ± 11.8 and 30.2 ± 11.4 years, p < 0.001). Pain and nodule/pustule formation were more frequent in neutrophilic PCAs (p < 0.001). Topical/intralesional corticosteroids and hydroxychloroquine were mainly used in lymphocytic PCAs, whereas oral antibiotics and isotretinoin were preferred in neutrophilic PCAs.</p><p><strong>Conclusions: </strong>PCA frequency may vary geographically. LPP-C was the most common subtype. Early diagnosis and timely treatment are essential to prevent irreversible hair loss and optimize cosmetic outcomes.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"35 1","pages":"23-30"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147595423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tatjana Radević, Tanja Tirnanić, Ivana Ilijin, Lidija Kandolf, Željko Mijušković
{"title":"Clinical characteristics, associated comorbidities, and treatment approaches in pyoderma gangrenosum: a single-center retrospective analysis.","authors":"Tatjana Radević, Tanja Tirnanić, Ivana Ilijin, Lidija Kandolf, Željko Mijušković","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Pyoderma gangrenosum (PG) is a rare destructive neutrophilic dermatosis of unknown etiology, associated with systemic diseases in approximately 50% to 75% of cases.</p><p><strong>Methods: </strong>We conducted a search of the hospital database to retrieve medical records of patients diagnosed with PG at our facility between 1995 and 2019. The diagnosis was validated through clinical characteristics, histopathological examination, and necessary tests to rule out other dermatoses. Data on demographics, disease presentation, comorbidities, and treatment strategies were collected and evaluated.</p><p><strong>Results: </strong>The analysis included 44 patients, 27 (61.4%) females and 17 (38.6%) males. The median age at presentation was 46.5 years (range 15-73). The most common location was the lower leg, in 32 (72.7%) patients. The ulcerative variant was found in 37 (84.1%) patients. In 11 patients (25%) an association with inflammatory bowel disease (IBD) was found. Hematological disorders occurred in five (11.4%) patients and rheumatoid arthritis in four (9.1%). Treatment was started with systemic corticosteroids (CS) in 36 (83.7%) patients, and pulse corticosteroid therapy was administered in five (11.4%) patients. The most frequently used steroid-sparing agent was dapsone, in 18 (40.9%) patients.</p><p><strong>Conclusion: </strong>PG often presents with associated systemic conditions, but it may also appear idiopathically. CS remain the mainstay of treatment, complemented by immunosuppressants and biologics such as infliximab for IBD-associated cases.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"35 1","pages":"7-11"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147595458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis in a psoriasis patient after sequential biologics including extended brodalumab: a case report.","authors":"Po-Yu Chen, Yu-Hsuan Ho, Chi-Shun Yang, Chien-Shan Chiu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biologic therapies have revolutionized psoriasis management, but they have also raised concerns about potential unusual adverse effects. We think this represents the first detailed case of subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis in a psoriasis patient, confirmed clinically and histopathologically, occurring after 9 months of brodalumab treatment following multiple biologic switches. The patient's development of subcutaneous panniculitis-like T-cell lymphoma during an extended period on brodalumab, compared to other biologics, underscores the need for awareness of potential rare complications associated with this therapy.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"34 ","pages":"55-58"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The impact of celebrities disclosing skin cancer: the example of Gordon Ramsay.","authors":"Nicolas Kluger","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Celebrity disclosures of health conditions can influence public awareness and searches for health information. On August 30th, 2025, Gordon Ramsay announced on Instagram (> 19 million followers) that he had undergone surgery for basal cell carcinoma (BCC). This study evaluates the impact of this announcement on online search behavior.</p><p><strong>Methods: </strong>Google Trends data were analyzed for the terms \"Gordon Ramsay,\" \"basal cell carcinoma,\" \"skin cancer,\" \"photoprotection,\" and \"sunscreen\" worldwide and in the United Kingdom from August 2023 to September 2025. Wikimedia Pageviews Analysis was used to assess daily visits to the BCC article in multiple languages.</p><p><strong>Results: </strong>Ramsay's announcement generated a marked but transient surge in searches for \"basal cell carcinoma,\" with an associated 1,800% increase in combined queries and a 218% rise in daily Wikipedia pageviews. The effect was most prominent in English-speaking countries and briefly in the Czech Republic following local media coverage. No increase was observed for prevention-related terms. Comparisons with other celebrities show that Ramsay had the highest impact over the past 9 years.</p><p><strong>Conclusions: </strong>Celebrity health announcements can trigger immediate spikes in public information seeking, but the effect is brief and geographically limited. However, heightened awareness may not necessarily lead to sustained engagement or preventive behavior.</p>","PeriodicalId":45914,"journal":{"name":"Acta Dermatovenerologica Alpina Pannonica et Adriatica","volume":"35 1","pages":"45-49"},"PeriodicalIF":1.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147594895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}